arrow
D

David E. Goldgar

university of california-san diego
H指数:66
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk

开发整合单基因,多基因和流行病学风险的乳腺癌风险预测模型

2024-09-110
PRE
Population-based Estimates of contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
2023-03-011
PRE
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach

临床,剪接和功能分析以分类BRCA2外显子3变体: 基于点的ACMG/AMP方法的应用

2022-10-236
OAAI
Population-based risk estimates of clinical subtypes of breast cancer among carriers of germline pathogenic variants in cancer predisposition genes
2022-02-150
PRE
Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits
2022-01-2010
OAAI
A Population-Based Study of Genes Previously Implicated in Breast Cancer

先前与乳腺癌有关的基因的基于人群的研究

2021-02-04473
OA
Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort
2020-12-109
OAAI
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women
2020-05-1949
OAAI
Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer
2020-03-0222
OAAI
Population-based breast cancer risk estimates for predisposition gene mutations: Results from the CARRIERS study
2020-02-150
PRE
Polygenic risk scores provide clinically meaningful risk stratification among women carrying moderate penetrance pathogenic variants in breast cancer predisposition genes: Results from the CARRIERS study
2020-02-150
PRE
A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
2020-02-01139
OAAI